Risky medicine
our quest to cure fear and uncertainty
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 390168033 | ||
| 003 | CHVBK | ||
| 005 | 20201005113245.0 | ||
| 008 | 161201s2015 xxu 00 eng|d | ||
| 015 | |a GBB5-97093 |2 bnb | ||
| 020 | |a 978-0-226-04971-7 |q hbk. | ||
| 035 | |a (IDSBB)006412257 | ||
| 035 | |a (IDSLU)001225561 | ||
| 035 | |a (NEBIS)010864474 | ||
| 035 | |a (VAUD)991005802029702852 | ||
| 035 | |a (RNV)008449342-41bculausa_network | ||
| 035 | |a (RERO)008449342 | ||
| 035 | |a R008449342 | ||
| 035 | |a (EXLNZ-41BCULAUSA_NETWORK)991020256099702851 | ||
| 040 | |a StDuBDS |d SzZuIDS BS/BE B452 |e kids | ||
| 050 | 0 | 0 | |a R151 |b .A76 2015 |
| 060 | 0 | 0 | |a 2015 J-601 |
| 060 | 1 | 0 | |a WA 11 AA1 |
| 072 | 7 | |a s1me |2 rero | |
| 082 | 1 | |a 610 |2 15 | |
| 082 | 0 | |a 610.289 |2 23 | |
| 100 | 1 | |a Aronowitz |D Robert A. | |
| 245 | 1 | 0 | |a Risky medicine |b our quest to cure fear and uncertainty |c Robert Aronowitz |
| 264 | 1 | |a Chicago |b The University of Chicago Press |c 2015 | |
| 300 | |a 278 Seiten | ||
| 504 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Risky medicine : our quest to cure fear and uncertainty -- The converged experience of risk and disease -- The social and psychological efficacy of risk interventions -- The Framingham heart study and the emergence of the risk factor approach to coronary heart disease : 1947-1970 -- Gardasil : a vaccine against cancer and a drug to reduce risk -- The rise and fall of the lyme disease vaccines : a cautionary tale for risk interventions in American medicine and public health -- Cancer survivorship : the entangled experience of risk and disease -- The global circulation of risk interventions -- Situating health risks : an opportunity for disease prevention policy -- Epilogue : the risk system | |
| 520 | 8 | |a Will ever-more sensitive screening tests for cancer lead to longer, better lives? Will anticipating and trying to prevent the future complications of chronic disease lead to better health? Not always, says Robert Aronowitz in Risky Medicine. In fact, it often is hurting us. Exploring the transformation of health care over the last several decades that has led doctors to become more attentive to treating risk than treating symptoms or curing disease, Aronowitz shows how many aspects of the health system and clinical practice are now aimed at risk reduction and risk control. He argues that this transformation has been driven in part by the pharmaceutical industry, which benefits by promoting its products to the larger percentage of the population at risk for a particular illness, rather than the smaller percentage who are actually affected by it. Meanwhile, for those suffering from chronic illness, the experience of risk and disease has been conflated by medical practitioners who focus on anticipatory treatment as much if not more than on relieving suffering caused by disease. Drawing on such controversial examples as HPV vaccines, cancer screening programs, and the cancer survivorship movement, Aronowitz argues that patients and their doctors have come to believe, perilously, that far too many medical interventions are worthwhile because they promise to control our fears and reduce uncertainty. | |
| 650 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd | |
| 650 | 7 | |a Risikofaktor |0 (DE-588)4050131-0 |2 gnd | |
| 650 | 2 | |a Preventive Medicine |0 (DNLM)D011315 | |
| 650 | 2 | |a Disease |0 (DNLM)D004194 | |
| 650 | 0 | |a Medicine, Preventive |z United States |x History |y 20th century | |
| 650 | 0 | |a Diseases |x Risk factors |x Social aspects |z United States | |
| 650 | 0 | |a Medical care |z United States |x History |y 20th century | |
| 650 | 1 | 2 | |a Preventive Medicine |x history |
| 650 | 2 | 2 | |a History, 20th Century |
| 650 | 2 | 2 | |a Risk Assessment |
| 650 | 2 | 2 | |a Risk Factors |
| 651 | 2 | |a United States | |
| 691 | 7 | |B u |u MS 6200 |2 idslu LR | |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 909 | 7 | |a UFBI-201806 |2 nebis EN | |
| 912 | 7 | |a me |2 SzZuIDS BS/BE | |
| 912 | 7 | |a 140 |2 IDS LU | |
| 912 | 7 | |a UMBCMEDGES |2 UMBC-201806 | |
| 949 | |B VAUD |F iuhm |b iuhm |j HMA 25225 DMb |c 810820001 | ||
| 949 | |B NEBIS |F UMBC |b UMBC |c ULCAR |j WA 11-50 | ||
| 949 | |B IDSLU |F LUUHL |b LUUHL |c UHFRE |j MS 6200 2015 | ||
| 949 | |B IDSBB |F B452 |b B452 |c 452LB |j MED_WA_108 12 |x NELB4521510 | ||
| 950 | |B IDSBB |P 100 |E 1- |a Aronowitz |D Robert A. | ||
| 950 | |B IDSLU |P 100 |E 1- |a Aronowitz |D Robert Alan |d 1953- |0 (DE-588)131663410 |e Verfasser |4 aut | ||
| 950 | |B NEBIS |P 100 |E 1- |a Aronowitz |D Robert Alan |d 1953- |0 (DE-588)131663410 |e Verfasser |4 aut | ||
| 950 | |B VAUD |P 100 |E 1- |a Aronowitz |D Robert A. |4 aut | ||
| 956 | 4 | |B NEBIS |C UZH50 |D EBI01 |a UMBC |u https://opac.nebis.ch/objects/pdf03/UMBC_978-0-226-04971-7_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |
| 956 | 4 | |B IDSLU |C ILU50 |D ILU01 |a LUZHB |u https://www.ub.unibas.ch/tox/HBZ/HT018717638/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |